| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |